Dr. B.O. Rothbaum has received research funding and grants from the Wounded Warrior Project, NIH, the Department of Defense, the National Science Foundation, the Bob Woodruff Foundation, and MAPS; she is a stockholder in Virtually Better; she has served as a consultant for Otsuka, Psychwire, Senseye, MAPS, Lykos, Jazz Pharmaceuticals, GoodCap, Transcend, and Penumbra; she serves on the scientific advisory boards for the Anxiety and Depression Association of America and the National Center for PTSD, and on the board of directors for Gratitude America; she receives royalties from Oxford University Press, American Psychiatric Publishing, Inc., and Emory University. Dr. A.O. Rothbaum reports no financial relationships with commercial interests.